Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

A recent study published in the Journal of Affective Disorders suggests that a single dose of psilocybin may offer hope for U ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...

"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 ...